These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36198355)

  • 21. The fibrillin-1 hypomorphic mgR/mgR murine model of Marfan syndrome shows severe elastolysis in all segments of the aorta.
    Schwill S; Seppelt P; Grünhagen J; Ott CE; Jugold M; Ruhparwar A; Robinson PN; Karck M; Kallenbach K
    J Vasc Surg; 2013 Jun; 57(6):1628-36, 1636.e1-3. PubMed ID: 23294503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
    Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
    J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin prevents thoracic aortic aneurysm and dissection in mice.
    Zhou B; Li W; Zhao G; Yu B; Ma B; Liu Z; Xie N; Fu Y; Gong Z; Dai R; Zhang X; Kong W
    J Vasc Surg; 2019 Mar; 69(3):921-932.e3. PubMed ID: 30253896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
    Dale M; Fitzgerald MP; Liu Z; Meisinger T; Karpisek A; Purcell LN; Carson JS; Harding P; Lang H; Koutakis P; Suh M; Batra R; Mietus CJ; Casale G; Pipinos I; Baxter BT; Xiong W
    PLoS One; 2017; 12(10):e0186603. PubMed ID: 29040313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TGFβ (Transforming Growth Factor β) Therapy With Betaglycan-Derived P144 Peptide Gene Delivery Prevents the Formation of Aortic Aneurysm in a Mouse Model of Marfan Syndrome.
    Arce C; Rodríguez-Rovira I; De Rycke K; Durán K; Campuzano V; Fabregat I; Jiménez-Altayó F; Berraondo P; Egea G
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):e440-e452. PubMed ID: 34162229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Rapamycin on the Expression of Redox Enzymes in Aortic Vascular Smooth Muscle Cells from Marfan Syndrome Mice.
    Mathies M; Krieg EM; Mohr F; Zaradzki M; Wagner AH
    Pharmacology; 2022; 107(11-12):615-622. PubMed ID: 36174498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin Prevents the Progression of Thoracic Aortic Aneurysm in Marfan Syndrome Mice.
    Guo G; Ott CE; Grünhagen J; Muñoz-García B; Pletschacher A; Kallenbach K; von Kodolitsch Y; Robinson PN
    Aorta (Stamford); 2013 Jun; 1(1):5-12. PubMed ID: 26798667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
    Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
    J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model.
    Okamura H; Emrich F; Trojan J; Chiu P; Dalal AR; Arakawa M; Sato T; Penov K; Koyano T; Pedroza A; Connolly AJ; Rabinovitch M; Alvira C; Fischbein MP
    Physiol Rep; 2017 Apr; 5(8):. PubMed ID: 28455451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology.
    Bhushan R; Altinbas L; Jäger M; Zaradzki M; Lehmann D; Timmermann B; Clayton NP; Zhu Y; Kallenbach K; Kararigas G; Robinson PN
    J Cell Mol Med; 2019 Apr; 23(4):2526-2535. PubMed ID: 30677223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion.
    Li G; Qin L; Wang L; Li X; Caulk AW; Zhang J; Chen PY; Xin S
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1110-H1119. PubMed ID: 28213405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome.
    Arif R; Zaradzki M; Remes A; Seppelt P; Kunze R; Schröder H; Schwill S; Ensminger SM; Robinson PN; Karck M; Müller OJ; Hecker M; Wagner AH; Kallenbach K
    Mol Ther Nucleic Acids; 2017 Dec; 9():69-79. PubMed ID: 29246325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice.
    Zhang F; Yao K; Liu Y; Zhou M; Zhang Y; Hong S; Wu J; Zhang C
    BMC Cardiovasc Disord; 2024 Aug; 24(1):417. PubMed ID: 39127656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin inhibits CaCl2-induced thoracic aortic aneurysm formation in rats through mTOR-mediated suppression of proinflammatory mediators.
    Cao J; Wu Q; Geng L; Chen X; Shen W; Wu F; Chen Y
    Mol Med Rep; 2017 Aug; 16(2):1911-1919. PubMed ID: 28656223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.